Stephen J. Salipante
University of Washington
H-index: 44
North America-United States
Top articles of Stephen J. Salipante
Upper Respiratory Microbiota and Lower Respiratory Disease in Hospitalized Children in Kenya: A Secondary Pilot Analysis of the Toto Bora Trial
2024/5
Development of advanced control material for reverse transcription-mediated bacterial nucleic acid amplification tests
Journal of Clinical Microbiology
2024/4/17
2023 Neer Award for Basic Science: Genetics of Cutibacterium acnes in Revision Shoulder Arthroplasty: A Large-Scale Bacterial Whole-Genome Sequencing Study
Journal of Shoulder and Elbow Surgery
2024/4/10
Evaluation of Pre-Analytical Variables for Human Papillomavirus Primary Screening from Self-Collected Vaginal Swabs
The Journal of Molecular Diagnostics
2024/3/15
Alterations in the fecal microbiota in patients with advanced cystic fibrosis liver disease after 6 months of elexacaftor/tezacaftor/ivacaftor
Journal of Cystic Fibrosis
2024/3/6
Longitudinal profiling of the intestinal microbiome in children with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor
Mbio
2024/2/14
Introduction of a recombineering oligonucleotide and a CRISPR–Cas9 gene-targeting plasmid into Staphylococcus aureus for generating a gene-deletion strain
Cold Spring Harbor Protocols
2024/2/1
Using CRISPR–Cas9-Based Methods for Genome Editing in Staphylococcus aureus
Cold Spring Harbor Protocols
2024/2/1
Oligonucleotide design and construction of a gene-targeting CRISPR–Cas9 plasmid in Escherichia coli for generating a gene-deletion strain in Staphylococcus aureus
Cold Spring Harbor Protocols
2024/2/1
Pulmonary co-infections detected premortem underestimate postmortem findings in a COVID-19 autopsy case series
Pathogens
2023/7/12
EPS5. 02 Faecal microbiota changes in patients with cystic fibrosis with 6 months of elexacaftor/tezacaftor/ivacaftor: preliminary findings from the PROMISE study
Journal of Cystic Fibrosis
2023/6/1
WS13. 05 The short-and long-term effects of antibiotic treatment on the oropharyngeal and fecal microbiota in infants with cystic fibrosis
Journal of Cystic Fibrosis
2023/6/1
Genomic reconstruction and directed interventions in a multidrug-resistant shigellosis outbreak in Seattle, WA, USA: a genomic surveillance study
The Lancet Infectious Diseases
2023/6/1
Mo1885 FECAL MICROBIOTA CHANGES IN CHILDREN WITH CYSTIC FIBROSIS WITH 1 MONTH OF CFTR MODULATOR THERAPY ELEXACAFTOR/TEZACAFTOR/IVACAFTOR: PRELIMINARY FINDINGS FROM THE PROMISE …
Gastroenterology
2023/5/1
Diagnosis of ovarian carcinoma homologous recombination DNA repair deficiency from targeted gene capture oncology assays
JCO Precision Oncology
2023/5
The Vaginal Microbiome of Transgender and Gender Nonbinary Individuals
Transgender Health
2023/3/21
In Vitro Selection Identifies Staphylococcus aureus Genes Influencing Biofilm Formation
Infection and Immunity
2023/3/15
Bartonella spp. infections identified by molecular methods, United States
2023/3
Windows into leishmaniasis epidemiology in the United States: September 2021 through August 2022
medRxiv
2023
Co-Authors
